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Cytochrome P450 oxidoreductase (POR) acts as an electron donor for all cytochrome P450 enzymes. Knockout mouse Por−/− mutants, which
are early embryonic (E9.5) lethal, have been found to have overall elevated retinoic acid (RA) levels, leading to the idea that POR early
developmental function is mainly linked to the activity of the CYP26 RA-metabolizing enzymes (Otto et al., Mol. Cell. Biol. 23, 6103–6116). By
crossing Por mutants with a RA-reporter lacZ transgene, we show that Por−/− embryos exhibit both elevated and ectopic RA signaling activity
e.g. in cephalic and caudal tissues. Two strategies were used to functionally demonstrate that decreasing retinoid levels can reverse Por−/−
phenotypic defects, (i) by culturing Por−/− embryos in defined serum-free medium, and (ii) by generating compound mutants defective in RA
synthesis due to haploinsufficiency of the retinaldehyde dehydrogenase 2 (Raldh2) gene. Both approaches clearly improved the Por−/− early
phenotype, the latter allowing mutants to be recovered up until E13.5. Abnormal brain patterning, with posteriorization of hindbrain cell fates and
defective mid- and forebrain development and vascular defects were rescued in E9.5 Por−/− embryos. E13.5 Por−/−; Raldh2+/− embryos exhibited
abdominal/caudal and limb defects that strikingly phenocopy those of Cyp26a1−/− and Cyp26b1−/− mutants, respectively. Por−/−; Raldh2+/− limb
buds were truncated and proximalized and the anterior–posterior patterning system was not established. Thus, POR function is indispensable for
the proper regulation of RA levels and tissue distribution not only during early embryonic development but also in later morphogenesis and
molecular patterning of the brain, abdominal/caudal region and limbs.
© 2006 Elsevier Inc. All rights reserved.Keywords: POR; Retinoids; P450 cytochromes; CYP enzymes; Limb development; Brain patterning; VasculogenesisIntroduction
Cytochrome P450 oxidoreductase (POR; previously named
CPR and CYPOR) is an NADPH-dependent protein essential
for transferring electrons to microsomal cytochrome P450⁎ Corresponding authors.
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doi:10.1016/j.ydbio.2006.10.032enzymes (CYP or P450; Strobel et al., 1995). This large super-
family of enzymes catalyzes oxidative metabolism of many
exogenous and endogenous compounds including environmen-
tal chemicals, drugs and dietary derived-compounds, such as
retinoids, as well as steroids, fatty acids and prostaglandins
(Hasler, 1999). Functional inactivation of the Por gene in mice
leads to severe developmental defects and death at embryonic
day (E) 9.5 (Otto et al., 2003; Shen et al., 2002). High-pressure
liquid chromatography (HPLC) analysis of Por−/− embryos
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could be partially rescued by feeding dams with a vitamin A-
deficient (VAD) diet (Otto et al., 2003). Widespread defects are
observed in Por−/− embryos, but it remains to be established
whether these defects are merely a consequence of abnormal
retinoid signaling, or whether other cytochrome P450-mediated
metabolic pathways might be involved.
Retinoic acid (RA), an active metabolite of vitamin A, is an
important signaling molecule during vertebrate embryonic devel-
opment and plays a pivotal role in pattern formation, organogen-
esis, cell proliferation, differentiation and apoptosis (Blomhoff,
1994; Chambon, 1996; Niederreither and Dollé, in press; Ross et
al., 2000; Sporn and Roberts, 1994). The three known members of
the CYP26 subfamily have been shown to act on RA and oxidize it
into more polar compounds that are prone to further metabolism
and inactivation (Fujii et al., 1997; MacLean et al., 2001; Tahayato
et al., 2003;White et al., 1997). The importance of RAmetabolism
by CYP26 P450s during embryonic development has been
demonstrated by the Cyp26a1 and Cyp26b1 null mouse models.
Both Cyp26a1−/− and Cyp26b1−/− genotypes are lethal.
Cyp26a1−/− embryos die at mid-late gestation and have multiple
organ defects, including caudal truncation with spina bifida
(MacLean et al., 2001; Sakai et al., 2001), while Cyp26b1−/− pups
die soon after birth due to respiratory defects (Yashiro et al., 2004).
Cyp26b1−/− mutants also have severe limb defects (Yashiro et al.,
2004). It has been shown in both Cyp26a1−/− and Cyp26b1−/−
mice that RA signaling is increased in areas where these genes are
normally expressed, suggesting that the corresponding enzymes
contribute to RA degradation (MacLean et al., 2001; Sakai et al.,
2001; Yashiro et al., 2004). To further demonstrate this point,
Niederreither et al. (2002a) showed that theCyp26a1−/− phenotype
can be rescued genetically by conditions which decrease RA
levels. Introduction of haploinsufficiency of the retinaldehyde
dehydrogenase 2 (Raldh2) gene, encoding for the main RA-
synthesizing enzyme during early embryogenesis (Niederreither et
al., 1999), rescued the lethal phenotype and development of
posterior structures in Cyp26a1−/− mutants (Niederreither et al.,
2002a).
Por−/− mutants are more severely affected (Otto et al.,
2003), and die much earlier during development, than either
Cyp26a1−/− or Cyp26b1−/− null mice. This may not be
surprising, considering that lack of POR would impair the
activity of all three CYP26 enzymes, and that these enzymes
may have partially redundant roles in the early embryo (H.
Hamada, personal communication). POR activity is necessary
for the function of all P450s and an additional possibility is that
other CYP subfamilies play important roles in embryonic
development and that lack of POR impairs their activities too.
Indeed, several P450s, including Cyp1a1, Cyp2r1 and Cyp2s1,
have been reported to be expressed during early mouse
embryogenesis (Choudhary et al., 2003, 2005), although there
are no available data about their tissue distribution or possible
function. Cyp1a1 knockout mouse mutants, however, are
viable and do not have any obvious defects (Ghanayem et al.,
2000).
In this work, we have used various approaches to dissect out
in detail the link between the Por−/− embryonic phenotype andabnormal RA signaling. To analyze RA signaling at the cellular
level, we crossed Por mutants with transgenic mice harboring a
RA-sensitive (RARE-hsp68-lacZ) reporter gene (Rossant et al.,
1991). We show that RA-reporter activity is both abnormally
high in regions of normal transgene expression, and ectopically
extends in cephalic and caudal regions of the Por−/− embryos.
We also used two strategies to experimentally lower the retinoid
levels in Por−/− mutants, either by culturing whole embryos in
serum-free defined medium, or genetically by haploinsuffi-
ciency of the Raldh2 gene. Both approaches led to a rescue of
the Por−/− mutants, the latter strategy allowing mutants to be
recovered up to E13.5 for further phenotypic analyses. We thus
found that Por−/− fetuses have an abdominal/caudal truncation
phenotype strikingly similar to that of Cyp26a1−/− mice, as well
as limb defects whose molecular analysis revealed a ‘prox-
imalization’ of cell fates, consistent with the abnormal limb
phenotype of Cyp26b1−/− mutants. Analysis of unrescued and
rescued Por−/− embryos revealed abnormal molecular pattern-
ing of various brain regions, consistent with known effects of
excess RA administration to wild-type embryos (Avantaggiato
et al., 1996; Simeone et al., 1995 and refs therein). Altogether,
our data concur in showing that a major developmental function
of POR is to allow proper homeostasis of RA both in early
embryogenesis and through the activity of P450 metabolizing
enzymes.
Materials and methods
Mice and embryo culture
Generation of mice with targeted disruptions of the Por (Otto et al., 2003)
and Raldh2 (Niederreither et al., 1999) genes has been described. For embryo
culture, pregnant females were sacrificed at E9.5 and embryos explanted from
uterus in DMEM (Invitrogen). Embryos with intact yolk sacs were collected and
immersed in warmed (37°C) culture medium in 50 ml screw top tubes (5 ml
medium/embryo; 1–2 embryos/tube). The culture medium consisted of
Knockout DMEM, 10% KSR (Knockout Serum Replacement), 1× N2
supplement, plus penicillin and streptomycin (all from Invitrogen) and 2% of
cell culture grade albumin (Sigma) (Moore-Scott et al., 2003). Tubes were
gassed with 40% O2, 5% CO2 and 55% N2 and placed into a roller-tube mouse
incubator at 37°C (Tanaka et al., 2000). After 24 h, cultured embryos were
dissected out of the yolk sac in DMEM and fixed in 4% paraformaldehyde.
Retinoic acid analysis and scanning electron microscopy
RA analysis was performed on frozen embryos and medium by using
automated online solid-phase extraction high-pressure liquid chromatography-
electrochemical detection (Otto et al., 2003) and verified by using single wave
UV detection.
For scanning electron microscopy, embryos were fixed in Peter's fixative
(1.25% glutaraldehyde, 1% paraformaldehyde in 0.1 M cacodylate buffer, pH
7.2) at 4°C. Embryos were post-fixed in 1% osmium in cacodylate buffer,
dehydrated in graded ethanol, placed in acetone, critically point-dried and
sputter-coated with gold/palladium. Specimens were viewed on a Philips XL30
emission scanning electron microscope.
In situ hybridization, X-gal assays and immunohistochemistry
In situ hybridizations (ISH) with digoxigenin-labeled riboprobes on whole-
mount embryos or on cryosections (10 μm) were performed as described
(Chotteau-Lelièvre et al., 2006). An Intavis InSituPro robot was used in some
cases; details at http://www.eumorphia.org/EMPReSS/servlet/EMPReSS.
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(Lennon et al., 1996) was used to generate a Por riboprobe; other template
plasmids were produced in house or kindly provided by Drs D. Duboule (Hoxd
genes), R. Hill (Msx1), C.C. Hui (Gli1), V. Papaioannou (Tbx5), A. McMahon
(Shh, En2), G. Martin (Fgf4, Fgf8, Fgf10), E. Olson (dHand), M. Petkovich
(Cyp26a1, b1) and C. Bradfield (Arnt, Hif-1α). Whole-mount X-gal assays of
embryos carrying the RARE-hsp68-lacZ reporter transgene were performed as
described (Rossant et al., 1991). Some labeled embryos were embedded in 1%
agarose and sectioned with a vibratome (35 μm). Immunolabeling using rat
monoclonal anti-PECAM-1, anti-Flk1 and anti-erythropoietin antibodies
(Pharmingen) was performed as described (Otto et al., 2003). For procedures
for conventional histology, hematoxylin–eosin staining and TUNEL assays, see
http://www.eumorphia.org/EMPReSS/servlet/EMPReSS.Frameset (Pathology,
Histology section). The experimental numbers are specified throughout the
text; if omitted, each given observation was made on at least 3 independent
mutants.
RNA isolation and reverse transcription PCR
Embryos were collected from timed matings of wild-type C57BL/6 mice or
Por+/− mutants (Otto et al., 2003), placed in Trizol (Invitrogen) and either
vortexed or homogenized (E9.5) to disrupt tissue. Total RNA was extracted
following the manufacturer's instructions and quantified using a 2100
Bioanalyzer (Agilent Technologies). RNA samples were diluted to 15 ng/μl
and treated with DNase I (Promega). First-strand cDNA synthesis was carried
out using 0.2 μg total RNA and 0.5 μg of poly-T oligonucleotide (15mer) with
M-MulV reverse transcriptase (Promega) in a final volume of 40 μl.
Amplification of exons 5–10 of the Por gene was carried out using 4 μl
cDNA from above and 10 pmol each of the following primers: forward 5′-
gccgacctgagcagcctgcct-3′ and reverse 5′-catcgagattgtttagagac-3′ with PuReTaq
Ready-to-Go PCR beads (Amersham Biosciences). PCR conditions were as
follows: 94°C for 5 min, 32 cycles of 94°C for 30 s, 55°C for 20 s, 72°C for 45 s.
GAPDH was amplified using the same conditions but with the following
primers: forward 5′-gtcgtggatctgacgtgcc-3′ and reverse 5′-tgcctgcttcaccaccttct-
3′. Products were visualized on a 1% agarose gel.Fig. 1. POR is required for regulating RA activity in mouse embryos. (A) RT-
PCR analysis of Por expression in E7.5, 8.5, 9.5 WT and E9.5 Por−/− embryos.
Full-length Por cDNAwas used as a positive control (left lane). (B, C) Whole-
mount in situ hybridization analysis of Por expression in E8.0 (B) and E10.5 (C)
wild-type embryos. Embryo hybridized with Por sense riboprobe (negative
control) shown as an inset. (D–I) X-gal analysis of RARE-lacZ reporter
transgene activity at successive developmental stages (D, E: E7.75; F, G: 6–8
somite-stages; H, I: E9.5) in WT and Por−/− embryos (as indicated above).
Panels (a–c) in panels F and G show transverse sections at successive cranio-
caudal levels (as indicated by black lines). Insert in I shows high magnification
of the heart (ht) region. Brackets in panels D, E indicate the headfolds, and
arrowheads point to prospective trunk mesoderm.Results
Spatio-temporal patterns of retinoic acid signaling in Por−/−
embryos
In order to address the question of whether the defects in
Por−/− embryos correlate with spatial changes in retinoic acid
signaling, we first investigated how lack of POR function
altered tissue distribution and levels of RA at different stages in
development. To do this, we examined the activity of the RA-
sensitive RARE-lacZ reporter transgene, harboring a tetrameric
repeat of the RARβ2 RA-responsive element linked to the
hsp68 minimal promoter (Rossant et al., 1991), in wild-type
(WT) and Por−/− embryos. For comparison, we monitored the
spatial pattern of Por transcripts between E7.5 and E9.5. Por
transcripts were detected at low levels by RT-PCR at E7.5 and
significantly increased at E8.5–E9.5 (Fig. 1A). In situ
hybridization of E8.5 embryos revealed ubiquitous low level
expression (Fig. 1B; compare with control sense riboprobe,
inset). Por transcripts remained widely expressed at E9.5 and
E10.5, apparently at higher levels in limb regions (Fig. 1C, and
data not shown).
Ectopic activation of the RARE-lacZ reporter transgene was
observed in Por−/− mutants as early as E7.5 (Figs. 1D, E; n=4).
While in WTembryos, most head tissues were devoid of RARE-
lacZ activity, in Por−/− embryos, graded β-galactosidaseactivity was seen along both neuroepithelium and mesenchyme
of the headfolds (Figs. 1D, E, brackets). At more posterior
levels, in regions where the reporter transgene was expressed in
WT embryos, activity was higher in Por−/− mutants (Figs. 1D,
E, arrowheads). In WT embryos at 6–8 somite-stages, the head
(including forebrain, midbrain and anterior hindbrain), the
caudal region and most of the heart were devoid of RARE-lacZ
transgene activity (Fig. 1F). In Por−/− embryos, both cephalic
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n=2). At E9.5, shortly before their death, Por−/− embryos ex-
hibited almost ubiquitous RARE-lacZ activity, except in dorsal
mid- and forebrain (Fig. 1I, bracket), and overall levels of
transgene activity were higher than in control embryos (compare
Figs. 1H and I; n=3). Altogether, these data indicate that, in the
absence of Por function, there is ectopic RA activity in tissues
such as the head, the caudal region and the heart, but also
increased RA signaling in tissues where it is normally present.
Raldh2 haploinsufficiency rescues Por−/− embryos
In order to test directly whether the increased levels of
retinoic acid signaling account for the Por−/− early embryonic
defects, we generated compound Por; Raldh2 mutants.
Retinaldehyde dehydrogenase 2 (RALDH2) is the main RA-
synthesizing enzyme acting during early embryogenesis, andFig. 2. Raldh2 haploinsufficiency rescues Por−/− embryos. (A–D) External morpholo
and arrowheads indicate exencephaly and spina bifida, respectively. Details of the bra
(E–G) X-gal assays of RA-reporter RARE-lacZ transgene activity in E7.75 control, P
reporter RARE-lacZ transgene activity in E9.5 control and Por−/−; Raldh2+/− embryo
region and forelimb bud, respectively. Panels Q and R are transverse vibratome secti
heart; me, mesenchyme; ot, otocyst; ov, optic vesicle; se, surface ectoderm; so, somheterozygous disruption of the Raldh2 gene has been shown to
result in decreased levels of RA signaling (Niederreither et al.,
1999, 2002b). Raldh2 haploinsufficiency might therefore be
expected to rescue the Por−/− phenotype.
Compound heterozygous (Por+/−; Raldh2+/−) mutants were
healthy and fertile. These mutants were bred and litters were
collected at various developmental stages between E8.5 and
E14.5. All Por−/−; Raldh2+/− mutants obtained at E9.5 and
E10.5 were better developed than their Por−/− littermates (Figs.
2A–D; see below). Furthermore, whereas no Por−/− embryos
were ever recovered at E11.5–E13.5, Por−/−; Raldh2+/−
mutants were obtained at 73% of the expected frequency at
E11.75 (n=32; 44 expected; see below). By E13.5, the
frequency of Por−/−; Raldh2+/− mutants dropped to 27%
(n=15, of which 8 were dead in utero and were not further
analyzed), and no viable Por−/−; Raldh2+/− mutants were ob-
tained at E14.5 (23 expected). Double null (Por−/−; Raldh2−/−)gy of E9.5 WT (A), Por−/− (B) and Por−/−; Raldh2+/− (C, D) embryos. Asterisks
nchial and forelimb bud regions are shown (upper and lower insets, respectively).
or−/− and Por−/−; Raldh2+/− embryos, respectively. (H–R) X-gal analysis of RA-
s (genotypes as indicated above). Panels K–M and N–P are details of the caudal
ons of the head. b1,b2, branchial arches; flb, forelimb bud; di, diencephalon; ht,
ites; tv, telencephalic vesicles.
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were severely truncated (i.e. a head or caudal trunk region
could not be identified) or were being resorbed (data not shown).
Por+/−; Raldh2−/− embryos died around E10.5 and were
phenotypically similar to Raldh2−/− mutants (data not shown).
A detailed comparison between E9.5 Por−/−; Raldh2+/−
mutant embryos (n=56) and Por−/− single mutants (n=21)
showed that many aspects of the mutant phenotype were rescued
by Raldh2 haploinsufficency, although there was phenotypic
variability. At E9.5, all Por−/−; Raldh2+/− mutants had
completed their axial rotation and, when compared to Por−/−
single mutants, had a more extended antero-posterior axis with
larger somites, and a better developed head (Figs. 2B–D).
However, in most of the compound mutants (n=54/56), the
midbrain remained open (asterisks), the heart did not turn
completely and the caudal region was truncated. They also
exhibited spina bifida (arrowhead) and exencephaly (Figs. 2C,
D). In most severe cases (35% of the compound mutants; n=20/
56), the head was clearly truncated (asterisk), the branchial
arches absent, the heart abnormal and the forelimb buds very
small (Fig. 2D). The remaining 65% of Por−/−; Raldh2+/−
mutants were almost normal in size, although the shape and size
of the branchial arches and limb buds were slightly smaller than
those of WT littermates (compare Figs. 2A and C).
To investigate whether the phenotypic defects that remained
in E9.5 Por−/−; Raldh2+/− embryos correlate with persistence
of abnormally high levels of endogenous RA, we generated
mutants harboring the RARE-lacZ transgene. When analyzed at
E7.5, the levels of RARE-lacZ activity in Por−/−; Raldh2+/−
mutants (Fig. 2F; n=2) were intermediate between those seen
in WT and Por−/− embryos (Figs. 2E and G, respectively). At
E9.5, all Por−/−; Raldh2+/−; RARE-lacZ embryos (n=6)
exhibited ectopic lacZ activity. In poorly rescued mutants
(n=4), lacZ activity was found throughout head tissues (Fig.
2J), whereas in the best rescued mutants (n=2) ectopic activity
was observed regionally, e.g. in the branchial arches and heart
(Fig. 2I). Section analysis showed ectopic lacZ activity in both
the surface ectoderm and mesenchyme of the head (Figs. 2Q,
R). Ectopic and/or abnormally high activity was also seen in
the forebrain neuroepithelium (compare telencephalic vesicles
or diencephalic/optic stalk region, brackets, in Figs. 2Q, R).
RA-reporter activity was detected right up to the extremity of
the abnormal tail bud of the compound mutants (Figs. 2L, M),
whereas such activity is normally absent from the tail bud of
WT embryos (Fig. 2K). This caudal activity was highest in
mutants that were poorly rescued (Fig. 2M). Also, whereas the
RARE-lacZ transgene is downregulated in distal cells of the
growing forelimb buds in WT embryos (Fig. 2N), in all
instances RA-reporter activity was seen up to the distal tip of
the buds in Por−/−; Raldh2+/− embryos (Figs. 2O, P,
arrowheads).
In summary, we have found that the Por−/− phenotype can be
significantly improved by Raldh2 haploinsufficiency. However,
since there is still ectopic RA-reporter transgene activity in both
the cephalic and caudal regions of these compound mutants, it is
not surprising that the rescue was not complete and abnorm-
alities were still consistently observed in head and tail.Abnormal brain patterning in Por−/− mutants
The availability of a genetic system which reduces RA
signaling from the start of development provides the opportu-
nity to explore phenotypic defects that originate in early
embryos and to see whether these abnormalities may be
consistent with known effects of altered embryonic RA
signaling. Both conditions of RA excess and deficiency are
known to affect patterning of specific brain regions (Avantag-
giato et al., 1996; Niederreither et al., 2000; Simeone et al.,
1995, and references therein). A preliminary analysis of Por−/−
embryos with two rhombomeric markers (Krox20 and Crabp1)
had suggested that the rhombencephalon may be abnormally
expanded (Otto et al., 2003). To analyze further brain
patterning, we performed a detailed molecular analysis in
both unrescued and genetically rescued E9.5 Por−/− mutants.
Analysis of Hoxb1 expression, which is normally restricted
to rhombomere (r)4 (Fig. 3A), showed an anterior expansion
extending almost to the apex of the head in Por−/− mutants (Fig.
3C). Ectopic Hoxb1 expression was also seen in Por−/−;
Raldh2+/− mutants, with an enlarged rhombencephalic domain
and clusters of expressing cells up to the presumptive midbrain
level (Fig. 3B), indicating that the expansion of the anterior
hindbrain identities was only partly rescued by genetically
lowering RA levels.
We monitored the pattern of more anterior brain structures by
analyzing Fgf8, whose expression is normally restricted to the
mid-hindbrain isthmus (Martinez et al., 1999) (Fig. 3D), and
Engrailed2 (En2), which demarcates a region-specific domain
along each side of the isthmus (Joyner, 1996) (Fig. 3G). Fgf8
transcripts were expressed at low levels over a wide area of the
brain in Por−/− mutants (Fig. 3F, bracket), suggesting an
inability to establish a discrete, functional mid-hindbrain
signaling region. In 2 out of 3 compound mutants, Fgf8 isthmic
expression was abnormally weak (Fig. 3E, inset), whereas the
third mutant additionally showed a rostral expansion of Fgf8
transcripts (Fig. 3E, main panel). We also observed abnormally
weak Fgf8 expression (if any) in the anterior neural ridge and
branchial region of both Por−/− and Por−/−; Raldh2+/− mutants
(Figs. 3E, F). En2 transcripts were barely detectable in Por−/−
embryos (Fig. 3I), probably as a consequence of low levels of
Fgf8 expression at the mid-hindbrain boundary (Liu and Joyner,
2001). En2 was expressed in compound mutants in a
neuroepithelial domain of almost normal size (Fig. 3H),
consistent with a rescue of the mid-hindbrain signaling region.
However, the location of the En2-positive domain close to the
optic vesicles suggested that the non-En2-expressing anterior
midbrain might be reduced in size (Fig. 5H). This was
confirmed by analyzing Otx2, which is expressed at high levels
in the WT midbrain and at lower levels in the telencephalic
vesicles (Martinez-Barbera et al., 2001) (Fig. 3J). In Por−/−
embryos, the region of high Otx2 expression was reduced in
size and was almost adjacent to the optic vesicles (Fig. 3L,
arrowheads). More rostrally, the telencephalic domain was also
severely reduced. These defects were partly rescued in Por−/−;
Raldh2+/− mutants, which displayed a larger Otx2 putative
midbrain territory (arrowheads in Fig. 3K). Foxg1, a marker of
Fig. 4. Rescue of vascular development in Por−/−; Raldh2+/− embryos. Whole-
mount in situ hybridization of Flk1 (A–C) and PECAM-1 immunodetection
(D–I) in E9.5 Por−/− andPor−/−; Raldh2+/− embryos (genotypes indicated
above). Panels D, F, H and E, G, I are comparative views of the branchial and
somitic region, respectively. aa, aortic arch; da, dorsal aorta; ht, heart.
Fig. 3. Abnormal brain patterning in Por−/− mutants. Whole-mount in situ
hybridization of Hoxb1 (A–C), Fgf8 (D–F), En2 (G–I), Otx2 (J–L) and Foxg1
(M–O) in E9.5 Por−/− and Por−/−; Raldh2+/− embryos (genotypes indicated
above). All main panels are profile views. Insert panels show dorsal views of
same embryos, except in I where profile view of another mutant is shown.
Arrowhead and bracket in panels E, F show abnormal Fgf8 expression in brain
neuroepithelium. Arrowheads in panels J–L indicate anterior and posterior
limits of high Otx2-expressing (presumptive midbrain) area. anr, anterior neural
ridge; ba, branchial arches; ov, optic vesicle; tv, telencephalic vesicle.
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embryos (Fig. 3O), further demonstrating defective develop-
ment of the anterior forebrain. This was partly rescued upon
Raldh2 haploinsufficiency (Fig. 3N).
Overall these results demonstrate abnormalities throughout
the brain of Por−/− mutants, with an abnormal expansion of the
posterior hindbrain, an improper establishment of the mid-hindbrain signaling region and a truncated mid- and forebrain.
These abnormalities are reminiscent of the effects of RA
exposure on WT mouse embryos (Simeone et al., 1995 and
references therein).
Rescue of vascular development in Por−/−; Raldh2+/− embryos
The early death of Por−/− embryos has been linked to a
defective development of the vascular system, and several genes
(Hif1α, Arnt, Flk1) crucial for embryonic vascular development
were found to be expressed at abnormally low levels in the
mutant embryos (Otto et al., 2003). We investigated whether
improved development of the vasculature might explain the
extended survival of the genetically rescued mutants. Flk1
(which encodes the VEGF-receptor 2) was used as a marker of
the developing vascular endothelia (Figs. 4A–C). Consistent
with previous observations (Otto et al., 2003), unrescued E9.5
Por−/− embryos showed a fragmentary endothelial network
from which the major blood vessels failed to develop (Fig. 4C;
n=2). In contrast, E9.5 Por−/−; Raldh2+/− embryos showed a
more elaborate vascular network, in which the dorsal aorta and
aortic aches were clearly seen (Fig. 4B; n=4). The heart
endothelial network was also better developed in the Por−/−;
Raldh2+/− mutants (Fig. 4B).
Vascular rescue was further shown by immunostaining for
platelet endothelial cell adhesion molecule 1 (PECAM-1) (Figs.
4D–I). A hierarchically organized vascular system with larger
vessels branching into smaller capillaries was visible in Por−/−;
Raldh2+/− embryos (e.g. at intersomitic levels: Fig. 4E,
arrowhead; n=3). Although not as elaborate as in control
littermates (Fig. 4E), this network contrasted with the poorly
organized vascular network seen in unrescued mutants (Fig. 4F,
arrowhead; n=2). PECAM-1 staining also showed the presence
of aortic arches in compound mutants, even when branchial
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compare with D and I).
These observations indicate that a decrease in embryonic RA
levels is able to improve the development of the vascular
network in Por−/− mutants. An incomplete formation of the
capillary network, possibly combined with impaired cardiac
function, could nonetheless explain the intra-uterine death of the
Por−/−; Raldh2+/− mutants.
Rescue of Por−/− embryos in a serum-free culture system
An additional approach was used to assess whether the Por−/−
phenotype might be improved by decreasing retinoid levels. We
performed experiments in which E9.5 Por−/− embryos were
explanted and cultured in defined serum-free medium (i.e. devoid
of any source of retinoids). We previously reported that the
endogenous all-trans-RA to all-trans-retinol (atRA/atROH) ratio
is elevated over 2-fold in E9.5 Por−/− embryos, when compared to
WT littermates (1.49 versus 0.64; Otto et al., 2003). HPLC
analysis was performed on whole embryos after 24 h of serum-free
culture, which gave an atRA/atROH ratio of 0.46 for pooled WT
and Por+/− embryos (n=9), and 0.64 for Por−/− embryos (n=5).
The difference in these values was not statistically significant and
thus the abnormal RA to retinol ratio observed in Por−/− mutants
appears to be normalized after 24 h of culture.Fig. 5. Rescue of Por−/− embryos in a defined serum-free culture system. (A–D) Sca
E9.5 and cultured for 24 h in serum-free medium (A–C: profile views; D: dorsal view
(E–H) and whole-mount in situ hybridization of Arnt (I, J) and Fgf8 (K, L) in E9.5
panel H indicate intersomitic vessels. Arrows in panel L point to punctate expression
aorta; fb, forebrain; fl, forelimb bud; hl, hindlimb bud; so, somites.The culture system supported substantial development of
both WT and Por−/− embryos (Figs. 5A–D) and in most of the
E9.5 Por−/− embryos (n=41) cultured for 24 h, some aspects of
the mutant phenotype were rescued (Table 1; Figs. 5B–D). At
the start of culture, all the mutant embryos lacked branchial
arches and limb buds, displayed an open neural tube and had
severe heart defects; 14 of these embryos had turned and had
12–16 somites, while the remaining 27 mutants had not turned
and had a shortened trunk with abnormal tail region. On
culturing, most mutant embryos developed forebrain vesicles,
rudimentary branchial arches and fore- and hindlimb buds and
their neural tube either partially or completely closed (Table 1;
Figs. 5B–D). Embryos that had not turned at the start of culture
underwent partial turning. However, 8 mutant embryos, which
were severely malformed at the start of culture, hardly improved
thereafter.
We performed molecular analyses which showed that,
similarly to previous experiments in which Por−/− embryos
were obtained from vitamin A-deficiency mothers (Otto et al.,
2003), vascular development was improved in cultured Por−/−
embryos. Immunostaining for PECAM-1 in cultured Por−/−
embryos revealed vascular rescue (Figs. 5E–H), including
formation of intersomitic vessels extending dorso-ventrally
(Figs. 5F, H, arrowheads) and communication between dorsal
aorta and branchial arch arteries (Fig. 5H, compare with culturednning electron micrographs of WT (A) and Por−/− (B–D) embryos collected at
showing incomplete neural tube closure). (E–L) Immunodetection of PECAM-1
embryos cultured for 24 h (genotypes indicated above). Arrowheads in panel F,
of Fgf8 in forelimb bud regions of the Por−/− embryo. aa, aortic arch; da, dorsal
Table 1












Por+/+/Por+/− Yes 25–37 3–4, fusion 4 Closed Yes Asymmetric, looped Yes >70
Turned Por−/− Yes 22–28 Rudimentary 2–4 Often closed Yes Asymmetric Yes 14
Barely viable Por−/− No 10–18 No 0–2 (fore-limb buds) Open No Asymmetric No 8
Unturned Por−/− Partial 18–24 Rudimentary 0–4 Partially closed Yes Asymmetric Yes 19
E9.5 wild-type and Por−/− embryos were cultured in Knockout DMEM containing 10% knockout serum replacement for 24 h. All Por−/− embryos survived the culture
conditions as judged by a beating heart.
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proteins crucial for embryonic vascular development was also
rescued, including Arnt (Figs. 5I, J) and Hif1α, Epo and Flk1
(data not shown). We also analyzed Fgf8 and Shh, genes pivotal
in limb outgrowth. Transcripts of neither gene were detected in
presumptive limb bud regions of E9.5 Por−/− embryos (Otto et
al., 2003) but in 2/2 E9.5 mutants cultured for 24 h, Fgf8 was
expressed in surface ectoderm of forelimb regions in a punctate
pattern (Fig. 5L, compare with K). Whereas Shh transcripts were
present in forelimb buds of cultured WT embryos, these were
detected at very low levels in only 1 out of the 3 cultured Por−/−
embryos examined (data not shown).
In summary, the embryo culture experiments provide an
additional demonstration that the Por−/− embryonic phenotype
is due to abnormal RA levels. They also show that it is possible
to improve this phenotype by experimentally decreasing
retinoid levels only from E9.5 onwards. These observations
are consistent with the idea that regulated RA levels are critical
for the sustained development of the embryonic vasculature,
elongation of the boby axis and outgrowth of the limb buds.
Por−/−; Raldh2+/− fetuses display Cyp26a1/b1−/− - like
phenotypic defects
Both the genetic rescue and the embryo culture system
concurred that a reduction in embryonic retinoid levels can
improve the Por−/− phenotype. Embryo culture did not allow
mutants to develop far beyond E9.5, but the availability of the
genetic system which extended Por−/− mutant survival for
several days provided the opportunity to examine for the first
time, POR function at later developmental stages. Therefore we
analyzed Por−/−; Raldh2+/− compound mutants at E12.5 and
E13.5 (Figs. 6 and 7; n=3 and n=10, respectively). All these
mutants were exencephalic (Fig. 6C, asterisk) and had a
truncated face with micrognathia (bracket). They also exhibited
spina bifida with caudal truncation and a sirenomelia-like
phenotype with abnormally close or sometimes fused hindlimbs
(Fig. 6C, inset).
Histological analysis of Por−/−; Raldh2+/− mutants revealed
severe brain defects: the telencephalic vesicles were hypoplastic
(compare Figs. 6B and D; data not shown), the optic stalks were
abnormally close together due to the lack of a third ventricle
(Fig. 6D), whereas more posteriorly, the diencephalic neuroe-
pithelium was open and disorganized (not shown). Por−/−;
Raldh2+/− mutants also had a partial midline fusion of the
posterior mesonephros and genital ridges (Fig. 6G, comparewith WT embryos, Fig. 6E) and a horseshoe kidney, with
midline fusion of posterior metanephric tubules (Fig. 6H). Their
abnormal caudal region contained ectopic patches of disorga-
nized neural tissue (Fig. 6H, nt*).
All Por−/−; Raldh2+/− mutants (n=7) obtained at E13.5 had
abnormal limbs (Figs. 7A–F). Five of these exhibited severely
truncated fore- and hindlimbs (Fig. 7B, compare with WT limbs,
Fig. 7A) with no organized skeletal patterning, as revealed by
whole-mount alcian blue staining (Figs. 7D, E). The other two had
better developed limbs, although reduced in size (Figs. 7C, F).
Analysis of Sox9, an early marker of precartilaginous condensa-
tions (Wright et al., 1995), showed that in E12.5 Por−/−; Raldh2+/−
mutants a central condensation had developed, which did not
properly branch to form distal (zeugopod, carpal or digit)
condensations (Fig. 7H, compare with WT precartilaginous
condensations: Fig. 7G). Thus, Por−/−; Raldh2+/− mutants exhibit
consistent limb abnormalities, which in the most severe cases are
characterized by a lack of branching of pre-skeletal condensations
according to the normal proximo-distal sequence.
Expression of the p21 gene, encoding a cdk inhibitor
specifically expressed in limb and trunk myogenic blastemas
(Hawke et al., 2003; Zhang et al., 1999), was almost unde-
tectable even in the best developed E13.5 Por−/−; Raldh2+/−
limbs, although its expression was seen at adjacent trunk levels
(Figs. 7I, J, and data not shown). As Pax3-expressing
presumptive muscle cells (Bober et al., 1994) were detected at
an earlier stage (E10.5) in the Por−/−; Raldh2+/− limb buds
(data not shown), muscle differentiation may either be delayed
or arrested in the Por−/−; Raldh2+/− mutant limbs.
Altogether, the abnormalities observed in Por−/−; Raldh2+/−
fetuses are clearly reminiscent of phenotypic defects previously
described in Cyp26a1−/− or Cyp26b1−/− null mutants. Thus, the
spina bifida, the abdominal and caudal defects phenocopy the
abnormal caudal phenotype of Cyp26a1−/− mutants (Abu-Abed
et al., 2001; Sakai et al., 2001), whereas the facial and limb
truncations are Cyp26b1−/− like abnormalities (Yashiro et al.,
2004; M. Petkovich, personal communication). These results
strongly suggest that the late Por−/− phenotype observed in
compound mutants results, at least in part, from an impairment
of CYP26s RA-metabolizing activity.
Molecular analysis of limb development in rescued and
non-rescued Por−/− embryos
The abnormal limb phenotype observed in Por−/−; Raldh2+/−
fetuses prompted us to investigate the molecular abnormalities
Fig. 6. Por−/−; Raldh2+/− fetuses display Cyp26a1/b1−/− like phenotypic defects. (A–D) Comparative profile views and frontal head sections (hematoxylin–eosin
staining) of E12.5 control and Por−/−; Raldh2+/− embryos (genotypes indicated above). Asterisk and bracket (C) point to an exencephaly and truncated facial region,
respectively. Insert shows an abnormal midline location of hindlimbs (hl) and open neural tube (nt*). (E–H) Comparative sections of the posterior abdominal cavity (E,
G) and lumbosacral region (F, H) in E12.5 control and Por−/−; Raldh2+/− embryos. Insert panels (E, G) show an intermediate section plane of the mesonephros. Note
midline fusion of mesonephros and metanephros in mutant. ao, aorta; fl, forelimb; gr, genital ridge; hg, hindgut; ms, mesonephros; mt, metanephros; nt*, abnormal
neural tissue; os, optic stalk; tv, telencephalic vesicle.
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resumed molecular analysis of non-rescued Por−/− embryos, in
which previous investigations led to the conclusion of a lack of
initiation of limb bud outgrowth (Otto et al., 2003). To investigate
the basis for this failure of limb development, expression of genesFig. 7. Limb defects in Por−/−; Raldh2+/−mutants. (A–C) External limb morphology
staining of E13.5 forelimbs. (G–J) Whole mount in situ hybridization of Sox9 (G, H
indicated above.involved in limb bud initiation was examined at E9.5 in non-
rescued mutants. Tbx5 was found to be expressed at comparable
levels in lateral plate mesoderm prospective forelimb regions of
both WT and Por−/− embryos (Figs. 8A, B) and transcripts of
genes believed to be downstream of Tbx5, such as Lef1 andat E13.5 (main panels: forelimbs; insets: hindlimbs). (D–F) Alcian blue cartilage
) and p21 (I, J) on E12.5 and E13.5 forelimbs, respectively. Embryo genotypes
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of WT and Por−/− embryos (data not shown). However,
expression of dHand and Msx1 was reduced in lateral plate
mesoderm of Por−/− embryos (Figs. 8C, D). These molecular
alterations, added to a lack of Fgf8 induction in the prospective
limb ectoderm (Otto et al., 2003), could explain the failure of limb
budding in the mutants.
Early limb development was also monitored at E9.5 in
genetically rescued mutants. In most of the Por−/−; Raldh2+/−
embryos, dHand was expressed at normal levels in lateral plate
mesoderm, but at abnormally low levels within the posterior
limb bud mesenchyme (Figs. 8E, F, arrows; n=3). In a few
severely affected compound mutants, expression of dHand was
undetectable within the limb buds and reduced in the flank (data
not shown; n=2).
Fgf8 expression was abnormal in the limb buds of all
analyzed Por−/−; Raldh2+/− mutants (n=5). About 25% of
Por−/−; Raldh2+/− embryos had rudimentary limb buds with no
detectable Fgf8 expression (Fig. 8H, inset), whereas the others
had well-developed buds with an apical ectodermal ridge (AER)
expressing Fgf8 at abnormally low levels (compare Figs. 8G and
H). Mkp3, a downstream target of FGF signaling, is normally
expressed in a distal to proximal gradient in WT limb buds (Fig.Fig. 8. Molecular analysis of limb development in Por−/− and Por−/−; Raldh2+/− em
dHand (C, D, main panels; E, F), Fgf8 (G, H), Mkp3 (I, J), Shh (K, L) and Gli1 (M
views of lateral plate mesoderm and budding limbs. In all other panels, limb buds a
samples collected at E10.5. Dashed lines (H, insets) indicate limb-trunk boundary. Arr8I; Dickinson et al., 2002). Its expression was barely detectable
in the most rudimentary limb buds of Por−/−; Raldh2+/−
embryos (data not shown), while in mutants with relatively
well developed buds it was expressed in the distal mesenchyme
(Fig. 8J). It is noteworthy that expression was unequal between
left and right forelimb buds, with lower levels in the right-side
buds (Fig. 8J).
Shh expression was undetectable in E9.5 Por−/−; Raldh2+/−
embryos with rudimentary limb buds (data not shown; n=3),
although some mutants with better developed limbs expressed
Shh as expected in posterior mesenchyme (compare Figs. 8K
and L; n=2). As observed for Mkp3, unequal left–right
expression was observed, with higher levels on the left side
(data not shown). Two Por−/−; Raldh2+/− mutants analyzed at
E10.5 showed no Shh expression in limbs (Figs. 8K, L, insets),
indicating that lack of expression is not simply due to retardation
of limb development. To assess the efficiency of SHH signaling,
we analyzed its target genes Patched (Ptc) (Goodrich et al.,
1996; Marigo et al., 1996b) and Gli1 (Marigo et al., 1996a).
Transcripts of both genes were barely detectable in the majority
(10/13) of mutant limbs, even in those that were morphologi-
cally well rescued (Figs. 8M, N; data not shown). Unequal
transcript levels were seen in most mutants, with lowerbryos. Whole-mount in situ hybridization of Tbx5 (A, B), Msx1 (C, D, insets),
, N) in E8.75–9.5 embryos, and Bmp2 (O, P) in E11.5 embryos. (A–D) Profile
re viewed from their dorsal aspects. Insets in panels K–N show additional limb
ows in panel F point to abnormally low dHand expression within limb bud cells.
76 V. Ribes et al. / Developmental Biology 303 (2007) 66–81expression in right-side limbs (Fig. 8N). Expression of Bmp2,
another SHH downstream gene, was absent or very low in
Por−/−; Raldh2+/− mutant limb buds both at E9.5 and E11.5
(Figs. 8O, P, and data not shown). Thus, the limb defects in
Por−/−; Raldh2+/− mutants correlate with more or less severe
deficiencies in FGF and SHH signaling.
We further investigated the molecular basis of abnormal limb
patterning in Por−/−; Raldh2+/− limbs by analyzing expression
of various Hox genes between E9.5 and E11.5. The expression
of Hoxd9 in E9.5 and E10.5 limb buds was similar in both WT
and compound mutants (data not shown). However, at E11.5
instead of being present in proximal (stylopodal/zeugopodal)
limb regions (Fig. 9A), Hoxd9 expression extended to the tip of
the truncated Por−/−; Raldh2+/− limb buds (Fig. 9B). Hoxd11,
which is normally expressed in two domains in zeugopod and
distal autopod (Fig. 9C), was expressed in a single domain
extending to the distal tip in E10.5 and 11.5 mutant limbs (Fig.
9D and data not shown). Hoxd12, which is expressed at high
levels in the autopod and at lower levels along the posterior
margin of the stylopod and zeugopod of E11.5 WT limbs (Fig.
9E), was expressed in a continuous posterior domain in Por−/−;
Raldh2+/− limbs, with higher levels at the very distal tip (Fig.
9F). Hoxd13 and Hoxa13 start to be expressed at E10.5 in theFig. 9. Abnormal patterning and increased retinoid signaling and Cyp26 gene express
B), Hoxd11 (C, D), Hoxd12 (E, F), Hoxd13 (G, H, main panels) and Hoxa13 (G, H,
transverse sections of E10.5 forelimb buds. (K, L) X-gal assays on transverse section
RARE-lacZ transgene. Dashed lines delineate limb bud shape. (M–P) Cyp26b1 and C
whole-mounts, respectively. Embryo genotypes indicated above.prospective autopod region of WT limb buds (Fig. 9G and data
not shown). At E10.5, the expression levels of these genes
appeared to be decreased in compound mutant limbs (data not
shown). Furthermore, at both E10.5 and E11.5, their expression
domains were confined to the posterior and distal margin of
Por−/−; Raldh2+/− limb buds (Fig. 9H and data not shown). In
contrast Meis2 expression, normally restricted to proximal limb
mesenchyme (Fig. 9I), extended along most of the distal
mesenchyme in E10.5 compound mutant limbs (Fig. 9J).
Altogether, this analysis suggests that Por−/−; Raldh2+/− limbs
are abnormally ‘proximalized’.
We investigated whether the molecular abnormalities in
Por−/−; Raldh2+/− mutants correlate with abnormal levels of
RA signaling, by assessing RARE-lacZ transgene activity in
E10.5 and 11.5 limb buds. At both stages, RA-reporter activity
extended much further distally along the limb buds of
compound mutants, and was also abnormally high proximally,
when compared to WT limbs (Figs. 9K, L). In the chick
embryo, Cyp26a1 and Cyp26b1 have been shown to respond
to administration of exogenous RA (Reijntjes et al., 2003,
2005). Therefore, we checked the expression of both these
genes in the compound mutants. Cyp26b1 is expressed in a
graded manner along the distal limb bud mesenchyme of E10.5ion in Por−/−; Raldh2+/− limbs. Whole-mount in situ hybridization of Hoxd9 (A,
insets) in E11.75 forelimbs (dorsal views). (I, J) Meis2 in situ hybridization on
s of E10.5 (insets) and E11.5 (main panels) forelimbs of embryos harboring the
yp26a1 in situ hybridization on transverse sections of E10.5 forelimbs and E11.5
77V. Ribes et al. / Developmental Biology 303 (2007) 66–81WT embryos (Fig. 9M). Its distribution was not altered in the
Por−/−; Raldh2+/− limb mesenchyme (Figs. 9M, N), although it
was specifically upregulated in vascular cells (see the punctuate
labeling in Fig. 9N). In contrast, while Cyp26a1 is not
significantly expressed at E11.5 in WT limbs (Fig. 9O), it was
expressed at relatively high levels in both the limb ectoderm and
mesenchyme of Por−/−; Raldh2+/− mutants (Fig. 9P). These
data support the idea that there is an increase in RA levels and/or
changes in tissue distribution in Por−/−; Raldh2+/− mutants. In
the present situation, however, the upregulation of these genes
will be ineffective in triggering a feedback mechanism that
normalizes RA levels because of lack of POR function.
Discussion
POR function is required for proper retinoic acid homeostasis
in the embryo
Previous characterization of Por knockout mutants (Otto et
al., 2003) had revealed an early embryonic lethal phenotype
whose main morphogenetic defects were consistent with
observations made on other mouse mutants in which RA levels
were affected (Abu-Abed et al., 2001, 2003; Sakai et al., 2001;
Yashiro et al., 2004), or in WT mouse embryos following
administration of excess RA at gastrula/neurula stages (Avan-
taggiato et al., 1996; Simeone et al., 1995 and references
therein). Furthermore, HPLC analysis had revealed an abnor-
mally high RA/Retinol ratio in Por−/− embryos, and their
phenotype was found to be improved when generated from
vitamin A-deficient mothers (Otto et al., 2003). These
observations led to the idea that the main role of POR during
embryogenesis is to allow proper function of RA-metabolizing
CYP26 enzymes.
In this study, we have used several approaches to show that
Por loss of function affects the levels and tissue distribution of
RA in the early embryo. By analyzing the pattern of activity of a
RA-responsive lacZ transgene, we found that already from the
neurula stage, Por−/− mutants exhibit ectopic activation of the
RA-reporter transgene, both towards the head and caudal
regions. This is likely to result from abnormal RA signaling
due to a lack of efficient metabolism by CYP26 enzymes.
Indeed, CYP26A1 is present already at gastrulation stages in
posterior mesoderm (Fujii et al., 1997), and its function is then
required during tail bud development (Abu-Abed et al., 2001,
2003; Sakai et al., 2001). Both CYP26A1 and C1 are present in
embryonic head tissues and eventually all three CYP26 enzymes
exhibit differential expression patterns in the developing
rhombencephalon (Fujii et al., 1997; MacLean et al., 2001;
Tahayato et al., 2003). Altogether, the ectopic RA signaling
activity in Por−/− embryos can be explained by an inability of
these enzymes to catalyze its region-specific metabolism. It is
interesting that the Por−/− embryonic phenotype is much more
severe than any of the individual Cyp26 loss of function
phenotypes (Abu-Abed et al., 2001; Sakai et al., 2001; H.
Hamada, M. Petkovich, personal communication). There is
evidence that these enzymes have partly redundant roles (H.
Hamada, personal communication), and in this respect thePor−/− mutation might be similar in its effects to what might be
observed in a combined Cyp2a1/b1/c1 loss of function.
It was somewhat unexpected, however, to observe in Por−/−
embryos an abnormally high activity of the RA-reporter
transgene at prospective trunk levels, where RA is normally
signaling and where CYP26 enzymes are relatively lowly
expressed. This could be because RA had accumulated in the
early embryo due to its continuing production in the absence of
nearby metabolic sinks in cephalic and posterior mesoderm
regions. An alternative explanation is that other P450s in
addition to CYP26 enzymes might be present in the embryo and
could play a role in RA metabolism. In vitro, several human
cytochrome P450s, including CYP1A1, CYP2C8, CYP2S1,
CYP1B1, and CYP3A7, have been shown to efficiently
hydroxylate RA (Chen et al., 2000;Marill et al., 2000;McSorley
and Daly, 2000). Although Cyp1a1 and Cyp2s1 have been
found by RT-PCR analysis to be expressed in E7mouse embryos
(Choudhary et al., 2005), there is no detailed report of their
early embryonic expression pattern. Further investigations are
warranted by our current results.
Reducing embryonic retinoid levels rescues vascular defects in
Por−/− embryos
We used two independent approaches to investigate function-
ally whether decreasing the levels of active embryonic retinoids
rescues the Por−/− phenotypic defects. In vitro culture of Por−/−
embryos in defined medium depleted from any source of reti-
noids, as well as decreased RA synthesis in Por−/−; Raldh2+/−
compound mutants, both improved their phenotypic defects. The
genetic rescue was most useful, as it extended survival and
allowed Por−/− mutants to be recovered up until E13.5. This
allowed characterization of morphological and molecular altera-
tions that cannot be assessed in unrescued mutants. The two main
phenotypic features of the genetically rescued mutants are spina
bifida and a caudal truncation phenotype clearly similar to that of
Cyp26a1−/− mutants (Abu-Abed et al., 2001; Sakai et al., 2001),
as well as limb defects (see below) that are consistent with the
phenotype of Cyp26b1−/− mutants (Yashiro et al., 2004). These
results further underscore the importance of POR in allowing a
proper control of embryonic RA levels through CYP26 function.
We provide evidence, both in the embryo culture and genetic
systems, that a partial rescue of the formation and/or remodeling
of the vascular system accounts for the improved viability of
Por−/− mutants. Recent studies carried out on Raldh2−/− mutants
demonstrated that RA deficiency affects remodeling and
patterning of the yolk sac and intra-embryonic vascular network,
although early formation of the capillary plexi occurs (Bohnsack
et al., 2004; Lai et al., 2003). Inactivation of Por also affects
early steps in vasculogenesis (Otto et al., 2003). This could result
from inappropriate RA signaling in the prospective vascular
endothelia, due to a lack of CYP26 metabolizing activity. Indeed,
both Cyp26a1 and Cyp26b1 are expressed in developing vascular
endothelia (MacLean et al., 2001; Reijntjes et al., 2005), and we
recently obtained evidence for incompletely penetrant defects in
vasculogenesis in Cyp26a1−/− embryos (V.R., P.D., unpublished
data).
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critical for capillary plexi development and erythropoiesis, such
as Hif1α and Arnt, is partially rescued by lowering retinoid
levels in Por−/− embryos. The downstream target gene of Hif1α,
Flk1, which is fundamental for vascular development (Shalaby
et al., 1995), was also rescued as seen by protein expression in
the major blood vessels of cultured and Raldh2 haploinsufficient
Por−/− mutants. However, analysis of its expression, as well as
of the endothelial marker PECAM-1, revealed that branches of
the network were abnormally dilated in cultured and compound
mutants, suggesting that RA homeostasis is not only required for
vasculogenesis but also for remodeling. The improvement in
forming a remodeled vascular network was more dramatic in
Por−/−; Raldh2+/− embryos compared to cultured Por−/−
embryos. This suggests that in order to allow normal vascular
development, RA metabolism must be controlled before E9.5.
Por function is required to protect anterior head cells from RA
signaling
RA is known to be one of the ‘posteriorizing’ factors acting
already during gastrulation and responsible for generating
posterior (hindbrain and spinal cord) fates in the prospective
CNS (Avantaggiato et al., 1996; Maden, 2002; Morriss-Kay et
al., 1991; Simeone et al., 1995). There is also evidence that, at
such early stages, rostral head development requires RA
receptors (RARs) to be in an unliganded (repressing) state
(Koide et al., 2001). As RA is a diffusible molecule, it is possible
that some mechanism(s) have evolved to prevent it inappropri-
ately activating gene targets in anterior regions of the embryo.
The CYP26A1 enzyme, which is transiently expressed in the
anterior embryonic epiblast and headfold neurectoderm, could
participate in such a function. However, rostral head develop-
ment in Cyp26a1−/− mouse mutants is relatively normal (Abu-
Abed et al., 2001; MacLean et al., 2001; Sakai et al., 2001), most
likely because another enzyme (CYP26C1) expressed in the
early headmesenchyme (Reijntjes et al., 2005; Sirbu et al., 2005)
could compensate for Cyp26a1 lack of function. Indeed,
compound Cyp26a1/c1 null mutants display severe head defects
consistent with those of Por−/− embryos (H. Hamada, personal
communication).
Our molecular analysis shows that, in the absence of POR, the
most anterior neural structures are absent (En2) or reduced
(Otx2, Foxg1), and that some hindbrain molecular markers are
extended anteriorly (Hoxb1). As these defects mimic those
observed after RA treatment of WT embryos at late gastrulation
stage (Avantaggiato et al., 1996), and as they are partially
rescued by lowering RA levels in Raldh2+/− compoundmutants,
our data show that an endogenous mechanism exists to protect
the anterior head region from the ‘posteriorizing’ effects of RA,
and that it relies on the metabolizing activity of P450 enzymes.
POR is required for limb patterning along both proximo-distal
and antero-posterior axes
Our study revealed that POR function is required at different
stages of limb development. Thus, we showed that lowering RAlevels in E9.5 cultured and genetically rescued Por−/− embryos
allow limb budding and formation of the apical ectodermal
ridge (AER). Earlier work has shown that excess of RA in pre-
bud mesenchyme in chick embryos can inhibit limb formation
(Wilde et al., 1987). In agreement with this study, we showed
that unrescued Por−/− mutants do not form an AER, as seen by
lack of Fgf8 expression. However, unlike in RA-deficient
embryos where important determinants of limb initiation, such
as Tbx5 and Fgf10, are not properly induced in lateral plate
mesoderm (Mic et al., 2004), in Por−/− mutants these genes
were correctly expressed. The reduction of RA levels in Por−/−;
Raldh2+/− compound mutants allowed onset of Fgf8 expression
and signaling in the mesenchyme, as seen by induction ofMkp3
at E10.5. At this stage, the ridge of Por−/− limb buds had an
irregular shape. This could be a consequence of reduced Bmp2
expression, which has been implicated in maturation of the AER
(Pizette et al., 2001; Pizette and Niswander, 1999). Abnormal
AER formation and/or maintenance could account for trunca-
tion of mutant limbs and increased cell death within the
mesenchyme.
Our analyses also showed that POR-dependent RA degrada-
tion is required for formation of distinct stylopodal, zeugopodal
and autopodal segments along the proximo-distal (P-D) axis of
the limb bud. The most severe limb phenotypes observed in
Por−/−; Raldh2+/− mutants resemble those described by Yashiro
et al. (2004) for Cyp26b1−/− mutants. Furthermore, a number of
similar molecular alterations indicate an abnormal ‘proximali-
zation’ of most of the limb bud in both types of mutants (see
Yashiro et al., 2004). We note, however, that while the scapula
was present in Cyp26b1−/− limbs, it was drastically affected in
∼70% of Por−/−; Raldh2+/− mutants. This could be the result
of an increase of RA signaling not only within the limb buds,
but also in the flank. Furthermore, our data indicate that
enhanced RA signaling in Por−/−; Raldh2+/− mutants also
affects the establishment of the limb antero-posterior (A-P) axis.
Expression of Shh, an important determinant of A-P polarity
(Charité et al., 2000; Chiang et al., 2001; and references
therein), was poorly rescued in Por−/−; Raldh2+/− mutants and
the SHH downstream target Gli1 (Marigo et al., 1996a) was
expressed at low levels in most of the compound mutant limb
buds. RA excess may actually affect A-P patterning of the limb
bud before induction of Shh expression. Indeed, dHand, which
is thought to control A-P pre-pattern (Fernandez-Teran et al.,
2000; te Welscher et al., 2002), was absent in the lateral plate
mesoderm of Por mutants and poorly rescued in compound
mutant limbs.
Another striking feature of impaired RA signaling is an
asymmetry between left and right limb buds, as shown here for
several factors, including Mkp3, Shh and Gli1, in the Por−/−;
Raldh2+/− mutants. Left–right asymmetrical limb phenotypes
have been previously reported in RA-deficient Raldh2−/−
mutants (Mic et al., 2004; Niederreither et al., 2002b). In the
RA-deficient mutants, left buds were consistently most affected,
whereas in the present case the most severe molecular
alterations are seen in right buds. Whether these asymmetries
reflect perturbation of a RA-dependent left–right stabilizing
activity along the embryonic paraxial (presomitic) and lateral
79V. Ribes et al. / Developmental Biology 303 (2007) 66–81mesoderm, as recently suggested (Kawakami et al., 2005;
Vermot et al., 2005; Vermot and Pourquié, 2005), remains to be
addressed.
Concluding remarks
This work has demonstrated that the early lethal Por loss
of function phenotype is linked to abnormal embryonic RA
signaling, and can be at least partially rescued by decreasing
the levels of retinoids delivered to (or synthesized by) the
embryo. The novel phenotypic defects that have been
characterized through our rescue experiments are consistent
with defective function of known CYP26 enzymes at later
stages of development, e.g. in the cephalic, hindbrain, limb or
tail bud regions. It remains to be seen if the severe phenotype
of unrescued Por−/− is merely the consequence of a combined
inactivation of all three CYP26s, and/or if other P450 enzyme
(s) with as yet uncharacterized early developmental functions
may additionally be involved. Comparative expression
profiling of mouse cytochrome P450 genes indicated that
transcripts of several P450s, including Cyp1a1, Cyp2r1 and
Cyp2s1 are expressed in early mouse development (Choudh-
ary et al., 2003, 2005). However, in the absence of detailed
spatio-temporal expression data and combined knock-out
models, it is difficult to conclude whether some of the
Por−/− phenotypic features may result from impaired activity
of non-CYP26 enzymes.
Nonetheless, the fact that absence of a functional microsomal
cytochrome P450 system leads to the severe developmental
defects described herein raises questions about the role of P450s
in teratogenicity. There are many examples of clinically adverse
drug reactions caused by inhibition of P450s (Guengerich,
1997; Tanaka, 1998) and it is possible that such inhibition of
P450 enzymes by drugs or environmental pollutants could
elevate RA to teratogenic levels. Investigation of compounds
which inhibit P450-mediated RA degradation could yield
insights into unknown mechanisms behind aborted births and/
or birth defects.
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